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Influence of white mineral trioxide aggregate
on inflammatory cells before and after expiry
date
Mineral trioxide aggregate (MTA) was developed as a
root-end ﬁlling material at Loma Linda University in
1993 (1). The principal components of this material are
tricalcium silicate, tricalcium aluminate, tricalcium oxide,
and silicate oxide (2). MTA is currently marketed in two
forms: gray (GMTA) and white (WMTA). Investigations
have shown that contrary to WMTA, the gray one
contains lower amounts of iron, aluminum, and magne-
sium, leading to discoloration potential of GMTA (3).
MTA has been used for pulp capping, pulpotomy, repair
of root perforations, apical barrier formation in non-vital
teeth with open apices, and root canal ﬁlling (4).
Although MTA has many indications in endodontics,
its usage is not as widespread as that of materials such as
composite resins, gutta-percha or root canal sealers,
luting agents, etc. in a general practitioner dental ofﬁce.
It has been reported that the shelf life of almost half of
dental cements and base/liner materials may be past the
manufacturer’s expiry date at the time of clinical use (5).
The period that dental materials are stored before use
and the conditions under which they are stored and
shipped to the user may have detrimental effects on their
physical, mechanical, and chemical properties, and
ultimately on their clinical efﬁcacy (6).
Some of the effects of aging on different dental
materials, such as gutta-percha (7), composite resins (8),
dental luting agents (9), and root canal sealers (10), have
been investigated. The inﬂuence of environmental con-
ditions on mechanical and physical properties of WMTA
has been investigated in some research studies, including
the evaluation of sealing ability at different pH values
(11), setting time (12, 13), surface hardness (14, 15), and
the morphology of WMTA stored under various condi-
tions (16). In addition, the effect of different storage
temperatures on microhardness, surface topography, and
phase structure of WMTA has been previously evaluated
(17). However, there is no available data on the physical
and chemical properties of expired MTA.
Several in vitro and in vivo tests are used to evaluate
the biocompatibility of dental materials, such as testing
the cytotoxicity of materials in a cell culture, implanta-
tion tests, and animal studies (4). The results of a meta
analysis showed that MTA is more biocompatible than
IRM, Super EBA, and silver amalgam (18).
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Abstract– Introduction: The aim of this study was to compare the effect of
subcutaneously implanted white mineral trioxide aggregate (WMTA) on
inﬂammatory reactions before and after expiry date. Methods: Fifty Wistar rats
were used in this study. Polyethylene tubes were ﬁlled with WMTA with expiry
dates of 2008, 2009, and 2011, and empty ones serving as the controls were
implanted into the subcutaneous tissue. The rats were sacriﬁced at 7-, 14-, 28-,
and 60-day intervals. 5-lm sections were stained with hematoxylin and eosin and
observed under a light microscope. Inﬂammatory reactions were categorized as
0, none (without inﬂammatory cells); 1, mild (inﬂammatory cells < 25); 2,
moderate (25–125 inﬂammatory cells); and 3, severe (more than 125 inﬂam-
matory cells). Statistical analysis was performed with Kruskal–Wallis test.
Results: All the experimental materials provoked moderate to severe inﬂam-
matory reactions after 7 days, which signiﬁcantly differed from the control
group (P < 0.05). At 14-day interval, WMTA with expiry date of 2008 and the
control group elicited mild to moderate inﬁltration of inﬂammatory cells.
However, WMTA with expiry dates of 2009 and 2011 provoked moderate to
severe inﬂammatory reactions, which were signiﬁcantly different from WMTA
with expiry date of 2008 and the control group (P < 0.05). At 28- and 60-day
intervals, the overall inﬂammation subsided in all the groups to mild to
moderate inﬁltration of inﬂammatory cells without any signiﬁcant differences
(P < 0.05). Conclusion: It seems that the expiry date has less negative effects on
the response of inﬂammatory cells. WMTA keeps its biocompatibility even after
expiry date.
A number of studies have investigated subcutaneous
responses to various types of MTA (19–23). There have
been some conﬂicting results regarding subcutaneous
reactions to white MTA (WMTA) and gray MTA
(GMTA; 19, 20). It has been reported that WMTA is
more biocompatible than GMTA after 3 days, but
GMTA is more biocompatible than WMTA after
7 days, with no signiﬁcant differences in their biocom-
patibility after 21 days (19). A study found no differences
between the inﬂammatory responses to GMTA and
WMTA (20). In a study, 2.5 wt% Na2HPO4 was added
to WMTA and a signiﬁcantly lower inﬂammatory
response was reported compared with WMTA when
the materials were implanted subcutaneously (22). To
date, there are no available data regarding the biocom-
patibility of expired MTA. Therefore, the aim of this
study was to evaluate the effect of subcutaneously
implanted WMTA on inﬂammatory reactions before
and after expiry date.
Materials and methods
The research protocol was approved by the Research
Ethics Committee of Kamal Asgar Research Center
(protocol no. KARC/10B2010-45-11). This study was
similar to those carried out previously (20, 22). Fifty 2–3-
month-old male Wistar albino rats weighting 250 ± 30 g
were used in this study. All the ethical and human criteria
contained in Helsinki declaration and all the recom-
mended points by Institutional Animal Care and Use
Committee in the care and use of laboratory animals were
observed in the different stages of the project. The
following materials were examined: ProRoot white
MTA sachets (Tooth-colored Formula; Dentsply Tulsa
Dental, Johnson City, TN, USA) were selected and
divided into three groups of 10 each as shown in Table 1.
Each sachet was mixed with its ampoule according to
manufacturer’s instructions under aseptic conditions.
The animals were anesthetized with diethyl ether using
the chamber induction method. Three separate 2-cm
incisions were made on the back of the rats at least 2 cm
away from each other. Freshly mixed materials were
prepared according to the recommendations of the
manufacturer. In expired ampoules, sterile distilled water
for injection was used to avoid the use of un-sterile
distilled water and compensate for lack of water to meet
powder/liquid ratio of 3:1 by weight. All the samples
were placed in sterile polyethylene tubes with a 1.1-mm
inner diameter and 8-mm length and were immediately
implanted subcutaneously in two separate incisions. An
empty polyethylene tube was implanted in the third
incision in each animal as a control at 7-, 15-, 30-, and
60-day intervals. The rats were euthanized by adminis-
trating a high dose of diethyl ether in an induction
chamber.
The tubes and surrounding tissues were removed in
block and ﬁxed in 10% buffered formalin solution for
2 weeks. 5-lm tissue sections were prepared longitudi-
nally through the midline of the tubes and stained with
hematoxylin and eosin. Quantitative evaluations of
inﬂammatory cells (lymphocytes, plasmocytes, polymor-
phonuclear leukocytes, macrophages, and giant cells)
were made in microscopic ﬁelds adjacent to the test
materials at the end of the tubes under a light microscope
(Carl Zeiss, Oberkochen, Germany) at ·500 magniﬁca-
tion. An average value for each specimen was obtained
from the sum of cells counted in four separate areas (24–
26). The observer did not have any knowledge of the
materials used in specimens. The overall mean value for
each material was determined in subjects at each period.
The inﬂammatory reactions were categorized as:
0: none (without inﬂammatory cells);
1: mild (<25 inﬂammatory cells);
2: moderate (25–125 inﬂammatory cells);
3: severe (more than 125 inﬂammatory cells).Kruskal–
Wallis and Mann–Whitney tests were used for statistical
analyses. Statistical signiﬁcance was deﬁned at P < 0.05.
Results
At 7-day interval, the mean inﬂammation grades were
2.6 ± 0.51, 2.4 ± 0.51, and 2.8 ± 0.42 for WMTA that
expired in 2008, 2009, and 2011, respectively, consisting of
moderate to severe inﬁltration of inﬂammatory cells
(Fig. 1). There were no signiﬁcant differences among the
groups (P = 0.2). At 14-day interval, the mean inﬂam-
mation grades were 1.8 ± 0.42, 2.3 ± 0.48, and
2.5 ± 0.52 for WMTA that expired in 2008, 2009, and
2011, respectively. MTA expiring in 2008 elicited mild to
moderate inﬁltration of inﬂammatory cells (Fig. 1). MTA
groups with expiry dates of 2009 and 2011 provoked
moderate to severe inﬁltration of inﬂammatory cells.
There were no signiﬁcant differences between WMTA
with expiry dates of 2009 and 2011 (P = 0.374), but
WMTA with expiry date of 2009 and 2011 showed
signiﬁcant differences from WMTA with expiry date
of 2008 and the control group (P < 0.05) (Fig. 2). At
28- and 60-day intervals, the overall inﬂammation
subsided in all the groups to mild to moderate inﬁltration
of inﬂammatory cells with no signiﬁcant differences
(P > 0.05) (Fig. 2).
Discussion
In this study, the 2008 group was selected to simulate
long-expired situation, 2009 was selected for short aging,
and the 2011 (before expiry) was selected as gold
standard. The executive part of this study was carried
out in spring 2010.
In this study, subcutaneous implantation was used to
evaluate the biocompatibility of materials. This method
was introduced in 1966 (24) and approved in 1981 (27).
In the current study, at the 7-day interval, all the
experimental groups evoked moderate to severe inﬂam-
matory reactions, which is partially consistent with the
ﬁndings of a research study (20), reporting that the
subcutaneous reaction to both types of MTA (WMTA
Table 1. Groups of MTA used in this study
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and GMTA) was a moderate, not severe, inﬁltration of
inﬂammatory cells at the 7-day interval. Another study
demonstrated mild to moderated inﬂammatory reactions
after subcutaneous implantation of WMTA after 7 days
(22). In this study, the difference between experimental
and control groups at 7-day interval was signiﬁcant, which
is consistent with the results of several studies (20, 22).
In this study, at 14-day interval, WMTA with expiry
dates of 2011 (un-expired WMTA) and 2009 provoked
moderate to severe inﬂammatory responses. Accordingly,
the results of some studies (20, 22) have shownmoderate to
severe reactions to un-expired implanted WMTA. In our
study, WMTA expired in 2008 signiﬁcantly provoked
fewer inﬂammatory reactions compared with WMTA
with expiry dates of 2009 and 2011 at 14-day interval.
This study showed that at 28- and 60-day intervals, all
the study groups (experimental and control) induced
mild to moderate inﬁltration of inﬂammatory cells.
Similarly, an investigation (20) reported mild to moder-
ate inﬂammatory reactions to 30- and 60-day subcuta-
neously implanted WMTA and GMTA samples. When
MTA powder is mixed with water, calcium phosphate
and calcium oxide are released from MTA, which
produce calcium hydroxide in contact with tissue ﬂuids
(28). Formation of calcium hydroxide is the cause of high
alkalinity of MTA after hydration (29), which is consid-
ered an initial tissue irritant when MTA comes into
contact with tissues (30). This would explain inﬂamma-





Fig. 1. Histologic images of inﬂammatory cell inﬁltration at the end of implanted tubes in the experimental groups (hematoxylin-
eosin staining; original magniﬁcation, ·400). (a, b, c) Seven-day WMTA with expiry dates of 2008, 2009, and 2011, respectively;
moderate inﬁltration (25–125) of inﬂammatory cells (lymphocytes, plasmocytes, polymorphonuclear leukocytes, and macrophages),
grade 2. (d, e, f) Fourteen-day WMTA with expiry dates of 2008, 2009, and 2011, respectively; mild to moderate inﬁltration of
lymphocytes, plasmocytes, and polymorphonuclear leukocytes is seen in WMTA with expiry dates of 2008. However, moderate to
severe inﬁltration of lymphocytes, plasmocytes, and polymorphonuclear leukocytes is seen in WMTA with expiry dates of 2009 and
2011. (g, h, i) Twenty-eight-day WMTA with expiry dates of 2008, 2009, and 2011, respectively; mild to moderate inﬁltration of
inﬂammatory cells (lymphocytes, plasmocytes, polymorphonuclear leukocytes, and macrophages) is seen in WMTA with expiry dates
of 2008, 2009, and 2011.
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In conclusion, although the physical properties of
WMTA may change over time, it seems that the expiry
date has less negative effects on the inﬂammatory cells
response. WMTA keeps its biocompatibility even after
expiry date. Further in vitro and in vivo experiments are
necessary to provide direct evidence for manufacturer-
determined expiry date for WMTA.
Conflict of interest
The authors deny any conﬂicts of interest related to this
study.
References
1. Torabinejad M, Chivian N. Clinical applications of mineral
trioxide aggregate. J Endod 1999;25:197–205.
2. Camilleri J, Pitt Ford TR. Mineral trioxide aggregate: a review
of the constituents and biological properties of the material. Int
Endod J 2006;39:747–54.
3. Roberts HW, Toth JM, Berzins DW, Charlton DG. Mineral
trioxide aggregate material use in endodontic treatment: a
review of the literature. Dent Mater 2008;24:149–64.
4. Parirokh M, Torabinejad M. Mineral trioxide aggregate: a
comprehensive literature review-part III: clinical applications,
drawbacks, and mechanism of action. J Endod 2010;36:400–13.
5. Hondrum SO. The US Army Institute of Dental Research
dental materials shelf-life survey: lot request results. Milit Med
1991;156:491–3.
6. Johnson GH, Herbert AH, Powers JM. Changes in properties
of glass-ionomer luting cements with time. Oper Dent 1988;13:
191–6.
7. Katz A, Tagger M, Tamse A. Rejuvenation of brittle gutta-
percha cones – a universal technique? J Endod 1987;13:65–8.
8. Tirapelli C, PanzeriI FC, PanzeriI H, PardiniII LC, Zaniquelli
O. Radiopacity and microhardness changes and effect of X-ray
operating voltage in resin-based materials before and after the
expiration date. Mat Res 2004;7:409–12.
9. Hondrum SO. Storage stability of dental luting agents.
J Prosthet Dent 1999;81:464–8.
10. Mendonc¸a SC, de Carvalho Ju´nior JR, Guerisoli DM, Pe´cora
JD, de Sousa-Neto MD. In vitro study of the effect of aged
eugenol on the ﬂow, setting time and adhesion of Grossman
root canal sealer. Braz Dent J 2000;11:71–8.
11. Saghiri MA, Lotﬁ M, Saghiri AM, Vosoughhosseini S, Fatemi
A, Shiezadeh V et al. Effect of pH on sealing ability of white
mineral trioxide aggregate as a root-end ﬁlling material. J Endod
2008;34:1226–9.
12. Kogan P, He J, Glickman G, Watanabe I. The effects of various
additives on setting properties of MTA. J Endod 2006;32:569–
72.
13. Huang T, Shie M, Kao C, Ding S. The effect of setting
accelerator on properties of mineral trioxide aggregate. J Endod
2008;34:590–3.
14. Namazikhah MS, Nekoofar MH, Sheykhrezae MS, Salariyeh
S, Hayes SJ, Bryant ST et al. The effect of pH on surface
hardness and microstructure of mineral trioxide aggregate. Int
Endod J 2008;41:108–16.
15. Saghiri M, Lotﬁ M, Saghiri A, Vosoughhosseini S, Aeinehchi
M, Ranjkesh B. Scanning electron micrograph and surface
hardness of mineral trioxide aggregate in the presence of
alkaline pH. J Endod 2009;35:706–10.
16. Camilleri J, Montesin F, Brady K, Sweeney R, Curtis R, Ford
T. The constitution of mineral trioxide aggregate. Dent Mater
2005;21:297–303.
17. Saghiri MA, Lotﬁ M, Joupari MD, Aeinehchi M, Saghiri AM.
Effects of storage temperature on surface hardness, microstruc-
ture, and phase formation of white mineral trioxide aggregate.
J Endod 2010;36:1414–8.
18. Ferna´ndez-Ya´n˜ez Sa´nchez A, Leco-Berrocal MI, Martı´nez-
Gonza´lez JM. Metaanalysis of ﬁller materials in periapical
surgery. Med Oral Patol Oral Cir Bucal 2008;1:13.
19. Shahi S, Rahimi S, Lotﬁ M, Yavari H, Gaderian A. A
comparative study of the biocompatibility of three root-end
ﬁlling materials in rat connective tissue. J Endod 2006;32:776–
80.
20. Vosoughhosseini S, Lotﬁ M, Shahi S, Baloo H, Mesgariabbasi
M, Saghiri MA et al. Inﬂuence of white versus gray mineral
trioxide aggregate on inﬂammatory cells. J Endod 2008;34:715–
7.
21. Gomes-Filho JE, Watanabe S, Bernabe¢ PF, de Moraes Costa
MT. A mineral trioxide aggregate sealer stimulated minerali-
zation. J Endod 2009;35:256–60.
22. Lotﬁ M, Vosoughhosseini S, Saghiri MA, Mesgariabbasi M,
Ranjkesh B. Effect of white mineral trioxide aggregate mixed
with disodium hydrogen phosphate on inﬂammatory cells.
J Endod 2009;35:703–5.
23. Parirokh MMB, Raoof M, Tabrizchi H, Haghdoost A.
Comparative study of subcutaneous tissue responses to a novel
root-end ﬁlling material and white and grey mineral trioxide
aggregate. Int Endod J 2011;44:283–9.
24. Torneck CD. The reaction of rat connective tissue to polyeth-
ylene tube implants. Oral Surg 1966;21:379–87.
25. Zmener O, Guglielmotti MB, Cabrini RL. Biocompatibility of
two calcium hydroxide–based endodontic sealers: a quantitative
study in the subcutaneous connective tissue of the rat. J Endod
1988;14:229–35.
26. Zmener O, Guglielmotti MB, Cabrini RL. Tissue response to an
experimental calcium hydroxide– based endodontic sealer: a
quantitative study in the subcutaneous connective tissue of the
rat. Endod Dent Traumatol 1990;6:66–72.
27. Olsson B, Slikowski A, Langland K. Subcutaneous implanta-
tion for the biological evaluation of endodontic materials.
J Endod 1981;7:355–69.
28. Koh ET, Mc Donald F, Pitt Ford TR, Torabinejad M. Cellular
response to mineral trioxide aggregate. J Endod 1998;24:543–7.
29. Camilleri J. Characterization of hydration products of mineral
trioxide aggregate. Int Endod J 2008;41:408–17.
30. Yaltrik M, Ozbas H, Biligic B, Issever H. Reactions of
connective tissue to mineral trioxide aggregate and amalgam.
J Endod 2004;30:95–9.
31. Islam I, Chng HK, Yap AU. Comparison of the physical and
mechanical properties of MTA and Portland cement. J Endod
2006;32:193–7.
Fig. 2. The mean inﬂammation grades in white mineral trioxide
aggregate with different expiry dates and test periods.
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